Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells

Document Details

Document Type
Pub Defense Publication
Publication Date
May 01, 2016
Source ID
10.1016/j.biochi.2016.01.014

Entities

People

  • Aditi Mathur
  • Amrita Datta
  • Asim B. Abdel-mageed
  • Debasis Mondal
  • Geetika Chakravarty
  • Joniece Willis
  • Pallavi Mallade
  • Samantha Gerlach
  • Sudesh Srivastav

Organizations

  • United States Department of Defense